Stockholders Equity (Tables)

3 Months Ended

Mar. 31, 2025

Equity [Abstract]

Schedule of Assumption Used for Stock Options Activity

The following weighted average assumptions were used for grants during the following periods:

	Three months ended March 31,
	2025	2024
Dividend Yield	n/a	0.00	%
Volatility	n/a	74.72	%
Risk-Free Interest Rate	n/a	4.17	%
Expected Life	n/a	3.50 years

Schedule of Stock Options Activity

A summary of stock option activity under the Company’s 2014 Plan for the three months ended March 31, 2025 is as follows:

Stock Options	Number of Shares	Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at January 1, 2025	281,913	$	2.71	3.74	$	3,517,111
Granted	—	$	—	—	$	-
Exercised	(50,000)	$	4.48	—	$	641,178
Expired/Forfeited	(3,333)	$	2.25	3.88	$	53,761
Outstanding at March 31, 2025	219,994	$	2.25	3.75	$	3,028,599
Vested and Exercisable at March 31, 2025	84,609	$	2.25	3.77	$	1,164,790

Schedule of the Restricted Common Stock Activity

A summary of the restricted Common Stock activity under the 2014 Plan and the 2024 Plan for three months ended March 31, 2025 is as follows:

Restricted Stock Awards	Shares	Weighted Average Grant Date Fair Value per Share		Aggregate Fair Value
Balance at January 1, 2025	267,586	$	5.24	$	1,402,151
Granted	70,934	$	15.31	$	1,086,187
Vested	(212,892)	$	3.63	$	(772,798)
Forfeited	—	$	—	$	—
Balance at March 31, 2025	125,628	$	13.66	$	1,716,078